Welcome back to Monday Delights!

This is your Monday morning dose of inspiration. Each week, I’ll share five intriguing investment ideas that recently caught my attention. These ideas are meant to spark your research and help you kickstart the week ahead with fresh insights.

Because these ideas are the result of my first-level idea generation process, they require more in depth research. Therefore, the ideas will often be concise, with occasional references to valuable work from other practitioners that I encourage you to explore.

If you have something fascinating to share that could benefit me and the wider community, don’t hesitate to send it my way—I’d love to hear from you!

Hugo Boss AG

• Market Cap: €2.7B
• EV: €3.6B
• ROE: 27.5%
• EV/FCF: 8.2

HUGO BOSS operates a premium fashion and lifestyle business built around its two core brands, BOSS and HUGO. The company designs, sources, markets, and sells apparel, footwear, and accessories for men and women, targeting different consumer segments through these distinct brands. Revenue is generated through a global omnichannel distribution model that combines directly operated stores, e-commerce, and wholesale partnerships. The company focuses on brand building, product innovation, and customer experience while leveraging a mix of in-house production and outsourced manufacturing. Its strategy is to position itself as a technology-enabled, customer-centric premium fashion platform capable of generating sustainable growth across both physical and digital channels.

I know that Germany and fashion are almost a contradiction, like the US and good food, but the appeal of Hugo Boss is that it is recognized as a premium business fashion brand that benefits from relatively stable annual fashion trends, making inventory obsolescence a lesser risk.

The company is still in a turnaround but seems to execute well. Cash generation is very strong and the debt burden is consistently shrinking. The company recently received a takeover bid by Frasers Group for €38 per share. The share price at the time of writing stands at €39.55. It really looks like Frasers is trying to acquire the company at an attractive price.

Athens International Airport S.A.

• Market Cap: €3.2B
• EV: €3.9B
• ROE: 31.6%
• P/E: 15.5

Athens International Airport operates Greece’s largest airport under a concession-based infrastructure model. Its business model combines aeronautical revenues, such as airline charges, passenger fees, and aircraft-related services, with non-aeronautical revenues generated from retail concessions, food and beverage outlets, parking, advertising, real estate leasing, and other commercial activities within the airport ecosystem. The airport benefits from increasing passenger traffic because both aviation-related and commercial revenues tend to rise as passenger volumes grow. This diversified revenue structure allows the airport to monetize not only aircraft movements but also passenger spending and the commercial value of its facilities.

Regulated air activities income (capped at a 15% ROE, ~70% of total revenues) combined with unregulated non-air activities income provides strong returns on equity, while its monopoly position ensures strong earnings visibility. The current Capex expansion will double the size of the airport but temporarily suppress FCF likely until 2028. Current FCF stands at ~€230M with normalized FCF around €400M. Essentially all FCF is paid out as a dividend, currently yielding around 5%.

Piraeus Port Authority S.A.

• Market Cap: €975M
• EV: €886M
• ROIC: 22.2%
• P/E: 11.3

Continuing our Greek journey, Piraeus Port Authority manages and operates the Port of Piraeus under long-term concession rights from the Greek state. Its business model is based on operating and monetizing a diversified maritime infrastructure platform that serves container shipping, cruise tourism, ferry passengers, vehicle handling, ship repair, and logistics activities. Revenue is generated both from directly operated port facilities and from concession arrangements with third-party operators, most notably container terminal operators. Because the port is a strategic gateway between Asia, the Mediterranean, and Europe, the company benefits from trade flows, passenger traffic, and tourism while earning fees, leases, and service revenues from a broad range of maritime activities.

Being one of the most strategic ports connecting Asia and Europe through the Mediterranean Sea, Piraeus Port Authority offers ownership of a piece of irreplaceable European infrastructure for just over 10x earnings. The port is currently undergoing a major expansion program that temporarily burdens FCF. Normalized FCF seems to be in excess of €100M, suggesting a valuation of just 9x EV/normalized FCF.

Plastika Kritis S.A.

• Market Cap: €408.0M
• EV: €285.9M
• ROE: 11.7%
• P/E: 11.7

Plastika Kritis is a specialized manufacturing company that produces plastic products and materials for industrial and agricultural applications. Its business model centers on developing and manufacturing masterbatches, plastic compounds, and agricultural films that are sold to customers worldwide. The company creates value through technical know-how, product customization, research and development, and long-standing customer relationships. Revenue is generated primarily from supplying inputs that improve the functionality, durability, and performance of plastic products used by other manufacturers and agricultural producers. Its international production footprint and export orientation allow it to serve a broad range of markets while benefiting from economies of scale and specialized expertise.

Gedeon Richter PLC

• Market Cap: HUF 2.2T
• EV: HUF 2.0T
• ROIC: 19.0%
• P/E: 9.5

Gedeon Richter is an innovation-driven pharmaceutical company that develops, manufactures, and markets medicines across multiple therapeutic areas. Its business model combines proprietary research and development with the production and commercialization of branded medicines, generic drugs, licensed products, and active pharmaceutical ingredients. The company has a particularly strong focus on women’s healthcare, neuropsychiatry, cardiovascular treatments, and other specialty pharmaceutical segments. In addition to selling its own pharmaceutical products, it generates revenue from partnerships, licensing arrangements, and contract development and manufacturing services. Its competitive advantage is built on substantial R&D capabilities, a broad product portfolio, and vertically integrated manufacturing operations.

That’s all for this week. I hope some of these ideas sparked your interest and inspired your research for the days ahead. If you’re looking for more inspiration for companies to explore, I recommend checking out last week’s article.

Have a great week!